TMCI

#3850
Treace Medical Concepts, Inc. Common Stock
2.25 USD
+5.63%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
2.25
2.28
Intervallo Annuale
1.17
7.78
Variazione giornaliera
+5.63%
Variazione Mensile
+52.03%
Variazione di 6 mesi
-63.53%
Variazione Annuale
-65.38%
Chiusura Precedente
2.13
Apertura
2.26
Bid
Ask
Minimo
2.25
High
2.28
Volume
163
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 145.33 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.63
Rapporto prezzo/fatturato
0.73

Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

Notizie